RecruitingNot Applicable

Aspiration Thrombectomy Using the Symphony or Prodigy System

United States750 participantsStarted 2026-02-13

Plain-language summary

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject is ≥ 18 years of age
✓. Subject is willing and able to comply with the follow-up schedule specified in this protocol
✓. Subject is willing and able to provide written informed consent prior to any study-related data collection
✓. Subject has a planned procedure, involving the use of Imperative Care vascular devices within their intended use

Exclusion criteria

✕. Subjects with any contraindications per the applicable Instructions for Use
✕. Subject with life expectancy of less than 1 year
✕. In the opinion of the Investigator, the patient is not a suitable candidate for intervention with Imperative Care devices
✕. Subject who may be unable to complete study follow-up

What they're measuring

Peripheral Arterial Cohort

Timeframe: 30 days

Peripheral Venous Cohort

Timeframe: 30 days

Pulmonary Embolism (PE) Cohort

Timeframe: 30 Days

Trial details

NCT IDNCT07350499

SponsorImperative Care, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2030-03

Contact for this trial

Sylvie Akiel-Fu, MPH

917-375-4735 safu@imperativecare.com

View on ClinicalTrials.gov More Arterial Thromboembolism trials